PLx Pharma Winddown Corp. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2014-06: Study NCT01594762; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2014-06: Study NCT01590758; Company role Lead sponsor; Phase Phase 3; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2014-06 | NCT01594762 Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers | Lead sponsor | Phase 3 | Completed Results posted | Diabetic Foot Infection | 200 | 2016-07 |
| 2014-06 | NCT01590758 Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers | Lead sponsor | Phase 3 | Completed Results posted | Diabetic Foot Infection | 189 | 2016-08 |